Inactive Instrument

Analyst Reco. InVitae Corp Nyse

Equities

End-of-day quote Nyse Other stock markets
-	-

Apr. 25	Labcorp beats quarterly estimates on strong testing demand	RE
Apr. 25	Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	RE

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Goldman Sachs Adjusts Price Target on Invitae to $0.50 From $1, Maintains Sell Rating	23-10-20	MT
Piper Sandler Trims Invitae Price Target to $0.50 From $1.50, Maintains Underweight Rating	23-08-15	MT
Goldman Sachs Adjusts Price Target on Invitae to $1 From $1.50, Maintains Sell Rating	23-07-21	MT
Piper Sandler Cuts Invitae's Price Target to $1.50 From $1.75, Maintains Underweight Rating	23-05-15	MT
Raymond James Downgrades Invitae to Underperform From Market Perform	23-05-15	MT
Piper Sandler Adjusts Invitae's Price Target to $1.75 From $2.25, Keeps Underweight Rating	23-03-03	MT
Goldman Sachs Downgrades Invitae to Sell From Neutral With $2 Price Target	23-01-31	MT
Credit Suisse Initiates Coverage of 20 Companies in Life Science Tools, Services, Diagnostics Sectors; Outperform-Rated Bio-Rad, IQVIA, Bipo-Techne, Natera Named Top Picks	22-08-25	MT
JPMorgan Downgrades Invitae to Underweight From Neutral	22-08-10	MT
Cowen Downgrades Invitae to Market Perform From Outperform, Adjusts Price Target to $2.50 From $8	22-07-26	MT
Raymond James Downgrades Invitae to Market Perform From Outperform	22-07-21	MT
Goldman Sachs Further Lowers Price Target for Invitae to $4 From $6, Maintains Neutral Rating	22-07-19	MT
Cowen Lowers Invitae's Price Target to $8 From $10, Maintains Outperform Rating	22-07-19	MT
SVB Securities Downgrades Invitae to Market Perform From Outperform, Adjusts Price Target to $2 From $8	22-07-19	MT
Benchmark Downgrades Invitae to Hold From Buy	22-07-19	MT
Goldman Sachs Adjusts Price Target for Invitae to $6 From $7, Maintains Neutral Rating	22-07-18	MT
Benchmark Adjusts Invitae's Price Target to $6 From $13, Reiterates Buy Rating	22-06-13	MT
Piper Sandler Starts Invitae at Underweight With $2.50 Price Target	22-06-03	MT
Raymond James Adjusts Invitae's Price Target to $8.50 From $10.50, Keeps Outperform Rating	22-05-05	MT
Raymond James Adjusts Invitae's Price Target to $10.50 From $15, Keeps Outperform Rating	22-04-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. InVitae Corp Nyse

Equities

Analyst Reco.

Filters